Results

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	RMSD	Seq. Identity (%)	HETATM
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	LEU A 205 HIS A 246 LEU A 253 ILE A 249	1.70A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	VAL A 202 HIS A 246 LEU A 287 ILE A 200	1.79A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	LEU A 227 LEU A 262 SER A 254 ALA A 260	1.64A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	ALA A 260 LEU A 253 ALA A 206 SER A 267	1.66A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	ALA A 266 LEU A 227 LEU A 262 ALA A 260	1.52A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	ALA A 206 LEU A 268 LEU A 208 ALA A 211	1.49A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	5rfc	3C-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	LEU A 208 VAL A 212 LEU A 250 ILE A 259	1.70A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6lzg	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 8	LEU B 461 ARG B 457 LEU B 425 ILE B 418	1.36A	16.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6m71	NSP12 (SARS-CoV-2)	4 / 8	LEU A 178 VAL A 174 LEU A 142 ILE A 171	1.42A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6m71	NSP12 (SARS-CoV-2)	4 / 8	LEU A 178 VAL A 174 LEU A 131 ILE A 171	1.43A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6m71	NSP8 (SARS-CoV-2)	4 / 8	LEU B 184 VAL B 160 LEU B 169 ILE B 166	1.53A	15.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6m71	NSP12 (SARS-CoV-2)	4 / 8	ALA A 253 LEU A 282 LEU A 251 ALA A 250	1.31A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6m71	NSP12 (SARS-CoV-2)	4 / 8	LEU A 245 LEU A 186 ALA A 250 ALA A 185	1.27A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6m71	NSP12 (SARS-CoV-2)	4 / 8	LEU A 142 TYR A 787 LEU A 247 ILE A 171	1.51A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6m71	NSP8 (SARS-CoV-2)	4 / 8	LEU B 117 VAL B 115 LEU B 98 ILE B 107	1.46A	15.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6m71	NSP8 (SARS-CoV-2)	4 / 8	LEU B 117 VAL B 115 LEU B 122 ILE B 106	1.47A	15.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6m71	NSP12 NSP7 (SARS-CoV-2)	5 / 8	ARG C 21 LEU C 14 ALA A 443 SER C 26 ALA C 30	1.38A	8.64	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6m71	NSP12 (SARS-CoV-2)	4 / 8	ALA A 376 LEU A 673 SER A 343 ALA A 379	1.31A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6m71	NSP12 NSP8 (SARS-CoV-2)	4 / 8	ALA A 399 LEU A 387 ALA B 150 ALA B 125	1.32A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6m71	NSP12 (SARS-CoV-2)	4 / 8	LEU A 498 TYR A 516 ARG A 513 ILE A 562	1.37A	20.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6vxs	NSP3 (SARS-CoV-2)	4 / 8	ALA A 124 LEU A 127 ALA A 129 ALA A 38	1.30A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6vxs	NSP3 (SARS-CoV-2)	4 / 8	LEU A 140 TYR A 113 VAL A 142 HIS A 138	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6vxs	NSP3 (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 122 ALA B 124 SER B 139	1.32A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6vxs	NSP3 (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.28A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6vxs	NSP3 (SARS-CoV-2)	4 / 8	LEU B 127 VAL B 49 LEU B 122 ILE B 23	1.44A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6vxs	NSP3 (SARS-CoV-2)	4 / 8	LEU B 140 TYR B 113 VAL B 142 HIS B 138	1.50A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6vxs	NSP3 (SARS-CoV-2)	4 / 8	ALA B 124 LEU B 127 ALA B 129 ALA B 38	1.25A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6vyb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 8	ARG A1014 ALA A1015 ALA B1016 SER A1021 ALA A1020	1.43A	17.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w02	NSP3 (SARS-CoV-2)	4 / 8	LEU A 127 VAL A 49 LEU A 122 ILE A 23	1.39A	15.03	None APR A 201 (-3.7A) None APR A 201 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 8	LEU C 452 VAL C 350 LEU C 455 ILE C 418	1.43A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 8	ALA C 363 LEU C 513 ALA C 397 LYS C 356	1.65A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 8	ALA C 363 LEU C 390 LEU C 387 SER C 366	1.45A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w41	SPIKE PROTEIN S1 (SARS-CoV-2)	4 / 8	LEU C 461 ARG C 457 LEU C 425 ILE C 418	1.33A	13.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6858 LEU A6959 SER A7074 ALA A6986	1.52A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6966 LEU A6857 LEU A6924 ALA A6858	1.73A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ARG A7030 ALA A6832 SER A6799 ALA A6802	1.26A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6808 LEU A6852 ALA A6966 ALA A7002	1.48A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6966 LEU A6978 LEU A7004 ALA A6990	1.51A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ARG A7081 ALA A6960 LEU A7073 SER A6964	1.40A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6986 LEU A6961 ALA A6960 ALA A6858	1.67A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6843 ALA A6997 SER A7039 ALA A6832	1.62A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ARG A7053 ALA A6858 LEU A7072 LEU A7073	1.69A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6997 LEU A7042 ALA A6843 LYS A6844	1.56A	14.16	None None None EDO A7103 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ARG A7081 ALA A6960 LEU A7078 LEU A7073	1.69A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	NSP10 (SARS-CoV-2)	4 / 8	ALA B4285 LEU B4365 ALA B4277 LYS B4278	1.65A	11.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	LEU A6893 ALA A6905 SER A6872 ALA A6877	1.34A	14.16	None None SAM A7104 (-4.4A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6870 LEU A6893 SER A6903 ALA A6905	1.56A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ALA A6802 LEU A7042 ALA A6843 ALA A6832	1.51A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	LEU A7072 ARG A7077 LEU A7060 ILE A7079	1.69A	14.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w61	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 8	ALA A6881 LEU A6887 LEU A6893 SER A6903 ALA A6905	1.70A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 88 LEU B 53 ALA B 56 ALA B 50	1.36A	14.23	None None None MES B 201 ( 3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 52 LEU B 123 ALA B 27 LYS B 28	1.37A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 52 LEU A 123 ALA A 27 LYS A 28	1.36A	14.23	AMP A 201 ( 4.0A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 127 ALA A 39 SER A 111 ALA A 112	1.70A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 127 LEU B 109 ALA B 112 LYS B 110	1.77A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	TYR B 113 VAL B 142 HIS B 138 LEU B 153	1.58A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 140 TYR A 113 VAL A 142 HIS A 138	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.28A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 38 LEU A 153 LEU A 126 ALA A 129	1.42A	14.23	AMP A 201 ( 3.9A) None AMP A 201 ( 4.4A) AMP A 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 124 LEU A 127 ALA A 129 ALA A 38	1.26A		None None AMP A 201 ( 3.4A) AMP A 201 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 12 TYR B 161 VAL B 165 LEU A 10	1.48A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	TYR B 161 VAL B 155 LEU A 10 ILE B 18	1.24A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 21 LEU A 123 ALA A 124 ALA A 27	1.45A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 153 LEU B 126 ALA B 124 ALA B 129	1.47A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 126 TYR B 113 VAL B 142 HIS B 138	1.79A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 129 LEU A 127 ALA A 112 ALA A 38	1.51A	14.23	AMP A 201 ( 3.4A) None None AMP A 201 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 109 LEU B 127 ALA B 112 ALA B 38	1.71A	14.23	None None None MES B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 88 LEU A 53 ALA A 56 ALA A 50	1.38A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 38 LEU B 153 LEU B 126 ALA B 129	1.39A	14.23	MES B 201 ( 3.4A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 127 VAL B 49 LEU B 122 ILE B 23	1.45A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 127 VAL A 49 LEU A 122 ILE A 23	1.37A		None AMP A 201 ( 3.7A) None AMP A 201 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 21 ALA A 27 LYS A 29 SER A 7	1.63A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 12 TYR A 161 VAL A 165 LEU B 10	1.51A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 27 LEU A 53 ALA A 38 ALA A 52	1.53A	14.23	None None AMP A 201 ( 3.9A) AMP A 201 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ARG A 148 LEU A 122 SER A 111 ALA A 112	1.49A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 127 ALA B 124 ALA B 38	1.67A	14.23	None None None MES B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 127 ALA A 124 ALA A 38	1.64A	14.23	None None None AMP A 201 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 52 LEU A 123 ALA A 124 ALA A 38	1.73A	14.23	AMP A 201 ( 4.0A) None None AMP A 201 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 88 ALA A 27 LYS A 28 ALA A 56	1.52A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 93 VAL B 35 LEU B 127 ILE B 23	1.60A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 27 LEU B 53 ALA B 50 ALA B 56	1.73A	14.23	None None MES B 201 ( 3.7A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 122 VAL A 35 LEU A 153 ILE A 23	1.80A	14.23	None None None AMP A 201 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 129 LEU B 127 ALA B 112 ALA B 38	1.53A	14.23	None None None MES B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 27 LEU B 53 ALA B 38 ALA B 52	1.60A	14.23	None None MES B 201 ( 3.4A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 140 TYR B 113 VAL B 142 HIS B 138	1.51A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 122 ALA B 124 SER B 139	1.27A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU B 126 ALA B 124 SER B 128 ALA B 129	1.69A	14.23	None None MES B 201 ( 4.5A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 122 ALA B 124 SER B 128	1.68A	14.23	None None None MES B 201 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 154 LEU B 164 LEU B 126 ALA B 129	1.76A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 124 LEU B 127 ALA B 129 ALA B 38	1.25A		None None None MES B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA A 27 LEU A 53 ALA A 50 ALA A 56	1.74A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	ALA B 21 LEU B 123 ALA B 124 ALA B 27	1.45A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 93 VAL A 35 LEU A 127 ILE A 23	1.60A	14.23	None None None AMP A 201 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w6y	NSP3 (SARS-CoV-2)	4 / 8	LEU A 10 TYR B 161 LEU B 169 ILE B 18	1.71A	14.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6870 LEU A6893 SER A6903 ALA A6905	1.62A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG C6864 ALA C6960 ALA C7056 ALA C6858	1.74A	14.34	FMT C7106 ( 2.7A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG C6864 ALA C6960 LEU C7078 ALA C7056	1.63A	14.34	FMT C7106 ( 2.7A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	LEU C6893 ALA C6905 SER C6872 ALA C6877	1.29A	14.34	None None SAM C7105 ( 4.4A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	5 / 8	ALA A6881 LEU A6887 LEU A6893 SER A6903 ALA A6905	1.73A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG A7081 ALA A6960 LEU A7073 SER A6964	1.39A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6858 LEU A6959 SER A7074 ALA A6986	1.53A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG C7081 ALA C6960 LEU C7073 SER C6964	1.38A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6966 LEU A6978 LEU A7004 ALA A6990	1.46A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG A7030 ALA A6832 SER A6800 ALA A6802	1.32A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6843 ALA C6997 SER C7039 ALA C6832	1.54A	14.34	None None FMT C7111 ( 3.2A) FMT C7111 ( 3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG C7081 ALA C6960 LEU C7078 LEU C7073	1.73A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6986 LEU A6961 ALA A6960 ALA A6858	1.68A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6966 LEU C6978 LEU C7004 ALA C6990	1.45A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6808 LEU C6852 ALA C6966 ALA C7002	1.42A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6808 LEU A6852 ALA A6966 ALA A7002	1.44A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6802 LEU A7042 ALA A6843 ALA A6832	1.55A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG C7053 ALA C6858 LEU C7072 ALA C6986	1.67A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6802 LEU C7042 ALA C6843 ALA C6832	1.56A	14.34	None None None FMT C7111 ( 3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG A6864 ALA A6960 LEU A7078 ALA A7056	1.66A	14.34	FMT A7106 ( 2.6A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	5 / 8	ALA C6881 LEU C6887 LEU C6893 SER C6903 ALA C6905	1.71A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	LEU A6893 ALA A6905 SER A6872 ALA A6877	1.29A	14.34	None None SAM A7102 ( 4.6A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6966 LEU C6857 LEU C6924 ALA C6858	1.72A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6997 LEU C7042 ALA C6843 LYS C6844	1.65A	14.34	None None None FMT C7108 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP10 (SARS-CoV-2)	4 / 8	ALA B4285 LEU B4365 ALA B4277 LYS B4278	1.73A	12.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG C7030 ALA C6832 SER C6799 ALA C6802	1.31A	14.34	None FMT C7111 ( 3.6A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6843 ALA A6997 SER A7039 ALA A6832	1.54A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6997 LEU A7042 ALA A6843 LYS A6844	1.58A	14.34	None None None FMT A7104 ( 4.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6858 LEU C6959 SER C7074 ALA C6986	1.53A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA A6966 LEU A6857 LEU A6924 ALA A6858	1.71A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP10 (SARS-CoV-2)	4 / 8	ALA D4285 LEU D4365 ALA D4277 LYS D4278	1.58A	12.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG A7053 ALA A6858 LEU A7072 LEU A7073	1.63A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG A6864 ALA A6960 ALA A7056 ALA A6858	1.76A	14.34	FMT A7106 ( 2.6A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG A7081 ALA A6960 LEU A7078 LEU A7073	1.73A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ALA C6986 LEU C6961 ALA C6960 ALA C6858	1.68A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w75	NSP16 (SARS-CoV-2)	4 / 8	ARG C7053 ALA C6858 LEU C7078 SER C7074	1.56A	14.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	ALA B 144 LEU B 152 LEU B 113 ALA B 116	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	LEU B 117 TYR B 136 LEU B 172 ILE B 123	1.24A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	ALA C 153 LEU C 172 LEU C 132 ALA C 131	1.13A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	5 / 8	ALA B 107 LEU B 152 LEU B 113 SER B 103 ALA B 114	1.76A		None None None CL B 502 ( 4.4A) CL B 502 ( 3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	ALA C 149 LEU C 172 LEU C 132 ALA C 131	1.18A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	LEU A 117 TYR A 136 LEU A 172 ILE A 123	1.20A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	5 / 8	ALA A 107 LEU A 152 LEU A 113 SER A 103 ALA A 114	1.71A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	ARG C 82 LEU C 172 LEU C 132 ALA C 131	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 8	LEU C 117 TYR C 136 LEU C 172 ILE C 123	1.08A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9q	3C-LIKE PROTEINASE PEPTIDE, NSP9 FUSION (SARS-CoV-2)	4 / 8	ALA A 15 LEU A 69 LEU A 44 ALA A 30	1.23A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6w9q	3C-LIKE PROTEINASE PEPTIDE, NSP9 FUSION (SARS-CoV-2)	4 / 8	ALA A 43 ALA A 54 SER A 46 ALA A 28	1.31A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wcf	NSP3 (SARS-CoV-2)	4 / 8	LEU A 127 VAL A 49 LEU A 122 ILE A 23	1.48A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wcf	NSP3 (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.27A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wcf	NSP3 (SARS-CoV-2)	4 / 8	ALA A 124 LEU A 127 ALA A 129 ALA A 38	1.24A		None None None MES A 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wen	NSP3 (SARS-CoV-2)	4 / 8	LEU A 140 TYR A 113 VAL A 142 HIS A 138	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wen	NSP3 (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wey	NSP3 (SARS-CoV-2)	4 / 8	ALA A 316 LEU A 326 ALA A 328 SER A 343	1.31A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wey	NSP3 (SARS-CoV-2)	4 / 8	LEU A 344 TYR A 317 VAL A 346 HIS A 342	1.56A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wey	NSP3 (SARS-CoV-2)	5 / 8	TYR A 317 VAL A 346 ARG A 345 HIS A 342 LEU A 357	1.73A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wiq	NSP8 (SARS-CoV-2)	4 / 8	LEU B 169 VAL B 186 LEU B 180 ILE B 132	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wiq	NSP7 NSP8 (SARS-CoV-2)	4 / 8	ALA B 150 LEU B 128 ALA B 126 SER A 57	1.22A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wiq	NSP7 NSP8 (SARS-CoV-2)	4 / 8	ALA B 110 LEU B 95 LEU A 56 SER A 61	1.28A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wiq	NSP8 (SARS-CoV-2)	4 / 8	LEU B 128 VAL B 186 LEU B 189 ILE B 156	1.50A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 8	ALA E 305 LEU E 291 SER F 310 ALA F 313	1.31A		CL E 401 ( 4.3A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	LEU A6893 ALA A6905 SER A6872 ALA A6877	1.32A		None None SAH A7102 ( 4.6A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	ARG C7030 ALA C6832 SER C6799 ALA C6802	1.26A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 8	ALA C6881 LEU C6887 LEU C6893 SER C6903 ALA C6905	1.73A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	LEU C6893 ALA C6905 SER C6872 ALA C6877	1.30A		None None SAH C7102 (-4.7A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wjt	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 8	ALA A6881 LEU A6887 LEU A6893 SER A6903 ALA A6905	1.74A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wkp	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 8	LEU C 161 LEU C 159 ALA C 173 ALA C 55	1.33A		None None None MES D 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wkp	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	4 / 8	LEU B 139 HIS A 59 LEU B 113 ILE B 146	1.50A		None ZN B 202 (-2.6A) None MES B 201 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wkq	NSP16 (SARS-CoV-2)	4 / 8	LEU C6893 ALA C6905 SER C6872 ALA C6877	1.28A		None None SFG C7103 ( 4.5A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wkq	NSP16 (SARS-CoV-2)	5 / 8	ALA A6881 LEU A6887 LEU A6893 SER A6903 ALA A6905	1.73A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wkq	NSP16 (SARS-CoV-2)	4 / 8	LEU A6893 ALA A6905 SER A6872 ALA A6877	1.29A		None None SFG A7103 ( 4.5A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wkq	NSP16 (SARS-CoV-2)	5 / 8	ALA C6881 LEU C6887 LEU C6893 SER C6903 ALA C6905	1.72A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU B 140 TYR B 113 VAL B 142 HIS B 138	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU C 127 VAL C 49 LEU C 122 ILE C 23	1.40A		None APR C 201 (-3.8A) None APR C 201 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.25A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA C 112 LEU C 122 ALA C 124 SER C 139	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA D 112 LEU D 122 ALA D 124 SER D 139	1.30A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU C 140 TYR C 113 VAL C 142 HIS C 138	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU B 127 VAL B 49 LEU B 122 ILE B 23	1.39A		None APR B 201 (-3.7A) None APR B 201 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA D 124 LEU D 127 ALA D 129 ALA D 38	1.21A		None None APR D 201 (-3.7A) APR D 201 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA B 124 LEU B 127 ALA B 129 ALA B 38	1.19A		None None APR B 201 (-3.7A) APR B 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA A 124 LEU A 127 ALA A 129 ALA A 38	1.19A		None None APR A 201 (-3.7A) APR A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU D 140 TYR D 113 VAL D 142 HIS D 138	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA C 124 LEU C 127 ALA C 129 ALA C 38	1.18A		None None APR C 201 (-3.7A) APR C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 122 ALA B 124 SER B 139	1.24A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU D 127 VAL D 49 LEU D 122 ILE D 23	1.38A		None APR D 201 (-3.6A) None APR D 201 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU A 140 TYR A 113 VAL A 142 HIS A 138	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU D 88 LEU D 53 ALA D 56 ALA D 50	1.32A		None None None APR D 201 ( 3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU A 127 VAL A 49 LEU A 122 ILE A 23	1.42A		None APR A 201 (-3.8A) None APR A 201 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	5 / 8	ALA A6881 LEU A6887 LEU A6893 SER A6903 ALA A6905	1.73A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wq3	2'-O-METHYLTRANSFERA SE (SARS-CoV-2)	4 / 8	LEU A6893 ALA A6905 SER A6872 ALA A6877	1.31A		None None SO4 A7109 (-4.5A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wqd	NSP7 NSP8 (SARS-CoV-2)	4 / 8	ALA B 110 LEU B 95 LEU A 56 SER A 61	1.33A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wqd	NSP8 (SARS-CoV-2)	4 / 8	LEU D 128 VAL D 186 LEU D 189 ILE D 156	1.42A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wqd	NSP8 (SARS-CoV-2)	4 / 8	LEU D 184 VAL D 160 LEU D 169 ILE D 166	1.57A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wqd	NSP7 NSP8 (SARS-CoV-2)	4 / 8	ALA B 150 LEU B 128 ALA B 126 SER A 57	1.21A		EDO B 302 (-3.7A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wqd	NSP7 NSP8 (SARS-CoV-2)	4 / 8	LEU D 122 VAL C 53 LEU D 128 ILE D 106	1.56A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wqd	NSP7 NSP8 (SARS-CoV-2)	4 / 8	ALA D 110 LEU D 95 LEU C 56 SER C 61	1.25A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wqd	NSP7 NSP8 (SARS-CoV-2)	4 / 8	LEU B 122 VAL A 53 LEU B 128 ILE B 106	1.57A		None EDO B 302 ( 4.8A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wqd	NSP7 NSP8 (SARS-CoV-2)	4 / 8	ALA D 150 LEU D 128 ALA D 126 SER C 57	1.24A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6wqd	NSP8 (SARS-CoV-2)	4 / 8	LEU B 128 VAL B 186 LEU B 189 ILE B 156	1.46A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6wrh	PEPTIDASE C16 (SARS-CoV-2)	5 / 8	ALA A 107 LEU A 152 LEU A 113 SER A 103 ALA A 114	1.75A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA A 260 LEU A 253 ALA A 206 SER A 267	1.63A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU A 208 VAL A 212 LEU A 250 ILE A 259	1.71A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA A 206 LEU A 268 LEU A 208 ALA A 211	1.49A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	LEU A 205 HIS A 246 LEU A 253 ILE A 249	1.71A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ARG A 279 LEU A 272 LEU A 287 SER A 284	1.46A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	VAL A 202 HIS A 246 LEU A 287 ILE A 200	1.79A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA A 266 LEU A 227 LEU A 262 ALA A 260	1.54A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yb7	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ALA A 210 LEU A 250 LEU A 253 SER A 301	1.73A	13.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yhu	REPLICASE POLYPROTEIN 1A (SARS-CoV-2)	4 / 8	LEU D 184 VAL D 160 LEU D 169 ILE D 166	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yhu	REPLICASE POLYPROTEIN 1A (SARS-CoV-2)	4 / 8	LEU D 128 VAL D 186 LEU D 189 ILE D 156	1.43A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yhu	REPLICASE POLYPROTEIN 1A (SARS-CoV-2)	4 / 8	ALA D 110 LEU D 95 LEU C 56 SER C 61	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yhu	REPLICASE POLYPROTEIN 1A (SARS-CoV-2)	4 / 8	ALA B 110 LEU B 95 LEU A 56 SER A 61	1.30A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6yhu	REPLICASE POLYPROTEIN 1A (SARS-CoV-2)	4 / 8	ALA D 150 LEU D 128 ALA D 126 SER C 57	1.20A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 8	LEU A 461 ARG A 457 LEU A 425 ILE A 418	1.40A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 8	LEU E 461 ARG E 457 LEU E 425 ILE E 418	1.39A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ynq	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	4 / 8	ARG A 279 LEU A 272 LEU A 287 SER A 284	1.16A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 8	LEU A 461 ARG A 457 LEU A 425 ILE A 418	1.40A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 8	LEU E 461 ARG E 457 LEU E 425 ILE E 418	1.39A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA D 124 LEU D 127 ALA D 129 ALA D 38	1.31A		None None EDO D 205 (-4.5A) EDO D 205 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU C 127 VAL C 49 LEU C 122 ILE C 23	1.40A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.27A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA B 124 LEU B 127 ALA B 129 ALA B 38	1.28A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU D 140 TYR D 113 VAL D 142 HIS D 138	1.55A		None None None EDO D 204 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 8	TYR D 113 VAL D 142 ARG D 141 HIS D 138 LEU D 153	1.79A		None None None EDO D 204 (-4.1A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU A 127 VAL A 49 LEU A 122 ILE A 23	1.41A		EDO A 202 ( 4.8A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA D 112 LEU D 122 ALA D 124 SER D 139	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	TYR E 113 VAL E 142 HIS E 138 LEU E 153	1.51A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU D 12 TYR D 161 VAL D 165 LEU E 10	1.44A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU E 127 VAL E 49 LEU E 122 ILE E 23	1.41A		None None None EDO E 205 (-4.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU E 140 TYR E 113 VAL E 142 HIS E 138	1.48A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU B 140 TYR B 113 VAL B 142 HIS B 138	1.56A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU A 140 TYR A 113 VAL A 142 HIS A 138	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 122 ALA B 124 SER B 139	1.27A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA C 112 LEU C 122 ALA C 124 SER C 139	1.30A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU D 93 VAL D 35 LEU D 127 ILE D 23	1.57A		None None None EDO D 208 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA E 124 LEU E 127 ALA E 129 ALA E 38	1.27A		None None None EPE E 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA C 124 LEU C 127 ALA C 129 ALA C 38	1.27A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU E 12 TYR E 161 VAL E 165 LEU D 10	1.54A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA E 112 LEU E 122 ALA E 124 SER E 139	1.27A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA A 124 LEU A 127 ALA A 129 ALA A 38	1.28A		None EDO A 202 ( 4.8A) None EDO A 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA E 112 LEU E 122 ALA E 124 SER E 139	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA A 124 LEU A 127 ALA A 129 ALA A 38	1.16A		None None APR A 201 ( 3.7A) APR A 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU B 140 TYR B 113 VAL B 142 HIS B 138	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA E 124 LEU E 127 ALA E 129 ALA E 38	1.17A		None None APR E 201 (-3.5A) APR E 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU E 127 VAL E 49 LEU E 122 ILE E 23	1.37A		None APR E 201 (-3.7A) None APR E 201 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.28A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU C 127 VAL C 49 LEU C 122 ILE C 23	1.38A		None APR C 201 (-3.6A) None APR C 201 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU D 127 VAL D 49 LEU D 122 ILE D 23	1.39A		None APR D 201 (-3.7A) None APR D 201 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	TYR E 113 VAL E 142 HIS E 138 LEU E 153	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA D 112 LEU D 122 ALA D 124 SER D 139	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU A 127 VAL A 49 LEU A 122 ILE A 23	1.38A		None APR A 201 (-3.7A) None APR A 201 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU D 140 TYR D 113 VAL D 142 HIS D 138	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 8	TYR D 113 VAL D 142 ARG D 141 HIS D 138 LEU D 153	1.74A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU E 140 TYR E 113 VAL E 142 HIS E 138	1.49A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	TYR D 161 VAL D 155 LEU E 10 ILE D 18	1.46A		None None EDO E 203 ( 4.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA C 112 LEU C 122 ALA C 124 SER C 139	1.30A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA D 124 LEU D 127 ALA D 129 ALA D 38	1.16A		None None APR D 201 (-3.4A) APR D 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU D 93 VAL D 35 LEU D 127 ILE D 23	1.55A		None None None APR D 201 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 122 ALA B 124 SER B 139	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA C 124 LEU C 127 ALA C 129 ALA C 38	1.16A		None None APR C 201 (-3.6A) APR C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU A 140 TYR A 113 VAL A 142 HIS A 138	1.55A		None None None EDO A 204 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU C 140 TYR C 113 VAL C 142 HIS C 138	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU E 12 TYR E 161 VAL E 165 LEU D 10	1.51A		None EDO E 203 (-4.0A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU B 127 VAL B 49 LEU B 122 ILE B 23	1.34A		None APR B 201 (-3.7A) None APR B 201 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU D 12 TYR D 161 VAL D 165 LEU E 10	1.46A		None None None EDO E 203 ( 4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA B 124 LEU B 127 ALA B 129 ALA B 38	1.18A		None None APR B 201 (-3.6A) APR B 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU A 127 VAL A 49 LEU A 122 ILE A 23	1.43A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 8	TYR C 113 VAL C 142 ARG C 141 HIS C 138 LEU C 153	1.74A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA A 112 LEU A 122 ALA A 124 SER A 139	1.31A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA B 112 LEU B 122 ALA B 124 SER B 139	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA A 124 LEU A 127 ALA A 129 ALA A 38	1.21A		None None None MES A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU B 127 VAL B 49 LEU B 122 ILE B 23	1.42A		None None None EDO B 202 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA C 124 LEU C 127 ALA C 129 ALA C 38	1.23A		None None None MES C 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU A 140 TYR A 113 VAL A 142 HIS A 138	1.55A		None None None EDO A 205 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA C 112 LEU C 122 ALA C 124 SER C 139	1.30A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU C 127 VAL C 49 LEU C 122 ILE C 23	1.43A		None None None EDO C 206 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	LEU C 140 TYR C 113 VAL C 142 HIS C 138	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	4 / 8	ALA B 124 LEU B 127 ALA B 129 ALA B 38	1.30A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP12 (SARS-CoV-2)	4 / 8	LEU A 178 VAL A 174 LEU A 142 ILE A 171	1.45A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP12 (SARS-CoV-2)	4 / 8	LEU A 498 TYR A 516 ARG A 513 ILE A 562	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP8 (SARS-CoV-2)	4 / 8	LEU B 117 VAL B 115 LEU B 122 ILE B 106	1.45A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7btf	NSP12 (SARS-CoV-2)	4 / 8	ALA A 253 LEU A 282 LEU A 251 ALA A 250	1.31A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP12 (SARS-CoV-2)	4 / 8	LEU A 178 VAL A 174 LEU A 131 ILE A 171	1.45A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP12 (SARS-CoV-2)	4 / 8	TYR A 915 VAL A 860 LEU A 895 ILE A 888	1.38A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP8 (SARS-CoV-2)	4 / 8	LEU B 184 VAL B 160 LEU B 169 ILE B 166	1.51A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP8 (SARS-CoV-2)	4 / 8	LEU D 128 VAL D 186 LEU D 189 ILE D 156	1.48A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7btf	NSP12 NSP8 (SARS-CoV-2)	4 / 8	ALA B 102 LEU B 98 ALA A 383 ALA B 125	1.32A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7btf	NSP7 NSP8 (SARS-CoV-2)	4 / 8	ALA D 110 LEU D 95 LEU C 56 SER C 61	1.24A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP12 (SARS-CoV-2)	4 / 8	LEU A 142 TYR A 787 LEU A 247 ILE A 171	1.52A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7btf	NSP12 (SARS-CoV-2)	4 / 8	LEU A 885 TYR A 915 ARG A 889 ILE A 856	1.57A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7buy	VIRUS MAIN PROTEASE (SARS-CoV-2)	4 / 8	LEU A 268 TYR A 209 LEU A 262 ILE A 259	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv1	NSP12 (SARS-CoV-2)	4 / 8	LEU A 142 TYR A 787 LEU A 247 ILE A 171	1.51A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7bv1	NSP12 NSP8 (SARS-CoV-2)	4 / 8	ARG B 80 ALA B 81 LEU A 514 ALA B 86	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv1	NSP8 (SARS-CoV-2)	4 / 8	LEU B 184 VAL B 160 LEU B 169 ILE B 166	1.55A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv1	NSP12 (SARS-CoV-2)	4 / 8	LEU A 498 TYR A 516 ARG A 513 ILE A 562	1.46A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv1	NSP12 (SARS-CoV-2)	4 / 8	LEU A 212 VAL A 182 LEU A 142 ILE A 244	1.47A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7bv1	NSP12 (SARS-CoV-2)	4 / 8	ALA A 253 LEU A 282 LEU A 251 ALA A 250	1.29A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7bv1	NSP12 (SARS-CoV-2)	4 / 8	LEU A 245 LEU A 186 ALA A 250 ALA A 185	1.31A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv1	NSP12 (SARS-CoV-2)	4 / 8	LEU A 178 VAL A 174 LEU A 142 ILE A 171	1.43A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7bv2	NSP12 (SARS-CoV-2)	4 / 8	ALA A 253 LEU A 282 LEU A 251 ALA A 250	1.28A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7bv2	NSP12 (SARS-CoV-2)	4 / 8	LEU A 245 LEU A 186 ALA A 250 ALA A 185	1.31A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv2	NSP12 (SARS-CoV-2)	4 / 8	LEU A 178 VAL A 174 LEU A 131 ILE A 171	1.47A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7bv2	NSP12 NSP7 (SARS-CoV-2)	4 / 8	ALA A 550 LEU C 41 ALA C 42 LYS C 43	1.10A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv2	NSP8 (SARS-CoV-2)	4 / 8	LEU B 117 VAL B 115 LEU B 122 ILE B 106	1.50A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA614_1 (SERUM ALBUMIN)	7bv2	NSP12 NSP8 (SARS-CoV-2)	5 / 8	LEU A 387 LEU B 128 ALA B 125 LYS B 127 ALA B 188	1.71A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv2	NSP8 (SARS-CoV-2)	4 / 8	LEU B 184 VAL B 160 LEU B 169 ILE B 166	1.53A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv2	NSP12 (SARS-CoV-2)	4 / 8	LEU A 178 VAL A 174 LEU A 142 ILE A 171	1.44A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	7bv2	NSP12 (SARS-CoV-2)	4 / 8	LEU A 142 TYR A 787 LEU A 247 ILE A 171	1.54A		None